Investor presentation July 9, 2018 A preliminary short form - - PowerPoint PPT Presentation

investor presentation
SMART_READER_LITE
LIVE PREVIEW

Investor presentation July 9, 2018 A preliminary short form - - PowerPoint PPT Presentation

Investor presentation July 9, 2018 A preliminary short form prospectus containing important information relating to the securities described in this document has not yet been filed with the securities regulatory authorities in each of the


slide-1
SLIDE 1

Investor presentation

July 9, 2018

A preliminary short form prospectus containing important information relating to the securities described in this document has not yet been filed with the securities regulatory authorities in each of the provinces of Canada. A copy of the preliminary short form prospectus is required to be delivered to any investor that received this document and expressed an interest in acquiring the securities. There will not be any sale or acceptance of an offer to buy the securities until a receipt for the final short form prospectus has been issued. This presentation does not provide full disclosure of all material facts relating to the securities

  • ffered. Investors should read the preliminary short form prospectus, final short form prospectus and any amendment, for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.
slide-2
SLIDE 2

2

General Prospective investors should rely only on information contained in the preliminary short form prospectus to be filed and delivered by the Company (the “prospectus”). This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the prospectus. A prospective investor is not entitled to rely on parts of the information contained in this presentation to the exclusion of others. The Company (“us”, “we” or “our”) nor the underwriters has authorized any other person to provide prospective investors with different information. If a prospective investor is provided with different or inconsistent information, the prospective investor should not rely on such information. Neither the Company nor the underwriters is making an offer to sell securities in any jurisdiction where such an offer or sale is

  • prohibited. Unless otherwise stated, the information contained in this presentation is accurate only as of the date of this presentation, regardless of the time of delivery of

this presentation or any sale of securities. The Company’s business, financial condition, results of operations and prospects may have changed since the date of this presentation. No securities regulatory authority has expressed an opinion about the securities and it is an offence to claim otherwise. The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be

  • ffered, sold, or delivered, directly or indirectly, in the United States, except pursuant to an exemption from the registration requirements of the U.S. Securities Act and

applicable state securities laws. The prospectus does not constitute an offer to sell or solicitation of an offer to buy any of these securities in the United States. All dollar amounts in this presentation are stated in Canadian dollars and references to dollars or “$” are to Canadian currency, unless otherwise indicated. Forward-Looking Information This presentation contains “forward-looking statements” within the meaning of applicable securities laws, such as statements concerning anticipated future events, results, circumstances, performance or expectations that are not historical facts. Use of words such as “may”, “will”, “expect”, “believe”, “anticipate” or other words of similar effect may indicate a “forward-looking” statement. Forward-looking information in this presentation includes: completion and timing of the proposed Acquisition and Offering; anticipated earnings and future growth rates; anticipated accretion in respect of earnings per share; forecasted operating expenses; the quantum and timing of estimated synergies and financial benefits to be derived in respect of such synergies; financial and acquisition metrics; and future growth initiatives. The Company believes the expectations reflected in such forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct and such forward- looking statements should not be unduly relied upon. Forward-looking information herein is based on various assumptions and expectations that Morneau Shepell believes are reasonable in the circumstances. No assurance can be given that these assumptions and expectations will prove to be correct. Those assumptions and expectations are based on information currently available to Morneau Shepell, including information obtained from third party sources, and the historic performance of Morneau Shepell’s businesses and those of LifeWorks. Such assumptions include anticipated financial performance, current business and economic trends, business prospects, currency, exchange and interest rates, cost estimates, Morneau Shepell’s ability to obtain financing on acceptable terms and the timing of satisfaction of the conditions to closing of the Acquisition, Morneau Shepell’s ability to achieve cost-efficiencies and cross-selling anticipated to achieve expected synergies, and are subject to the risks and uncertainties set forth below. Readers are cautioned that the preceding list of assumptions is not exhaustive.

slide-3
SLIDE 3

3

These forward-looking statements are not guarantees of future performance and are subject to numerous risks and uncertainties, including those described in the Company’s publicly filed documents (available on SEDAR at sedar.com). Those risks and uncertainties include ability to maintain profitability and manage growth, reliance on information systems and technology, reputational risk, dependence on key clients, reliance on key professionals and economic conditions. Many of these risks and uncertainties can affect the firm’s actual results and could cause the Company’s actual results to differ materially from those expressed or implied in any forward-looking statement made by the Company or on the firm’s behalf. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. All forward-looking statements in this presentation are qualified by these cautionary statements. These statements are made as of the date of this presentation and, except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Additionally, the Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, its financial or operating results or its securities.

Non-IFRS Measures

To assist investors in assessing the LifeWork's financial performance, this presentation makes reference to certain financial measures such as EBITDA. The Company believes that EBITDA is a useful supplemental measure to assist our investors in assessing LifeWorks’ financial performance. This financial measure does not have any standard meaning prescribed by International Financial Reporting Standards and therefore may not be comparable to similar measures presented by other issuers. "EBITDA" is defined as profit before finance costs, income tax expenses, depreciation and amortization.

slide-4
SLIDE 4

4

Transaction overview

Morneau Shepell ("MSI") has entered into a definitive agreement to acquire LifeWorks, a leading global Employee Assistance Program ("EAP") and wellness provider Purchase price of approximately C$426mm (US$325mm), payable in cash and MSI shares Key LifeWorks executives are taking back MSI shares as part of their consideration, with certain lock-up periods on the MSI shares Concurrent with the acquisition announcement, MSI announced a C$210mm bought deal equity offering of subscription receipts and an upsize in its bank facility to finance the cash portion of the purchase price Represents a purchase price multiple of approximately 11.2x anticipated 2019 EBITDA including in year synergies Acquisition is anticipated to be over 10% accretive to EPS in 2019 excluding acquisition- related amortization of acquired intangibles and including in year synergies

slide-5
SLIDE 5

5

LifeWorks overview

LifeWorks is a leading global EAP and wellness provider with a recurring revenue business model Enhanced technology platform that delivers an integrated employee wellness offering. Best- in-class user experience and support services help improve employee health and productivity Formed as a joint venture through the combination of Ceridian HCM, Inc.’s (“Ceridian”) core EAP business with WorkAngel's technology platform for employee rewards and recognition LifeWorks was spun out of Ceridian prior to Ceridian's 2018 IPO and for 2017, LifeWorks generated revenue of C$105mm Offices in U.S., the U.K., Australia and Canada, with more than 500 employees worldwide and 4,200+ existing customers across 57 industries (technology, medical and pharmaceuticals, benefits, banking and finance, insurance, hospitality and consulting)

slide-6
SLIDE 6

6

Strategically compelling

Consistent with our growth strategy and vison to optimize the health and productivity of people – the heart of every organization Geographically, we are leaders in complementary areas and together we are one of the largest EAP leaders Strong complementary capabilities to provide a comprehensive clinical and technology experience Combined organizations offer a one-stop shop to meet employers’ and their employees’ well-being needs across the globe

slide-7
SLIDE 7

7

Consistent with each pillar of our growth strategy

Expands employee well-being product offering and enhances EAP capabilities

Core business

Increases U.S./International revenue contribution from 15% to 24%

U.S. expansion

Transforms EAP delivery through a unified platform that vaults us ahead of the competition

Technology

Creates single point of contact for employees, improving user experience and driving cross-selling results

Collaboration

Addresses multiple well-being challenges simultaneously for clients and their employees

Transformation

slide-8
SLIDE 8

8

Social work communities Rewards & recognition HR communication Financial/legal Perks & savings Training Fitness/nutrition

Analytics & reporting

Digital counselling Coaching Online group Internet-based cognitive behavioural therapy Telemedicine Workplace support programs

Creating a one-stop end to end well-being platform

End to end well-being platform

Engagement Clinical treatment

Build and sustain mental and physical health Treat mental and physical health issues

slide-9
SLIDE 9

9

Geographically, we are leaders in complementary areas and together we are one of the largest EAP leaders

Morneau Shepell LifeWorks Well established presence U.S. U.K. Australia Canada Market leader in Canada Growing presence in the U.S. Multi-nationals with expats in multiple global locations International strength with joint ventures in emerging markets

slide-10
SLIDE 10

10

Financially attractive

High-quality, stable cash flow and earnings profile from LifeWorks’ core EAP business (~97 % of revenue), complemented by upside of enhanced offerings LifeWorks’ Adjusted EBITDA margin in line with Morneau Shepell’s Acquisition is anticipated to be over 10% accretive to EPS in 2019 excluding acquisition- related amortization of acquired intangibles and including in year synergies Expected to generate significant run-rate synergies of ~C$15mm by 2020, with ~C$10mm achieved in 2019, primarily from cost synergies

slide-11
SLIDE 11

11

Financing structure

Purchase price: C$426mm (US$325mm)

Total Sources C$mm Excess cash on hand $5 Incremental debt $200 Public equity $210 MSI shares issued to LifeWorks employees $31 Total $446 Total uses C$mm Cash consideration $395 MSI shares issued to LifeWorks employees $31 Total purchase price $426 Transaction and other costs $20 Total $446 Expected closing at end of July 2018 Pro-forma leverage is estimated to be approximately 2.8x

slide-12
SLIDE 12

Acquisition is aligned with Morneau Shepell’s strategy

12

To optimize the health and productivity

  • f people – the heart of every successful
  • rganization

Our purpose

Improving business Improving lives

Our values

We value long-term relationships We treat others the way we want to be treated We are innovative and entrepreneurial

Our people

Ensure we have engaged talent with right skills to execute strategic plan

Our clients

Create great client experiences

Transform how we do business and achieve best in class efficiency Collaborate across LOBs to increase client value and drive growth Drive successful execution of

  • ur core

businesses Accelerate growth through U.S. expansion Deploy new technology solutions to address macro HR trends Foundation Strategy Vision